GBSN could actually sell the company for their 6 assays to some major buyer interested in getting into the molecular diagnostics infectious disease market - $25-30 million is where it could go for including the notes it still owes. So I use that as a rule of thumb when considering what is a good price to buy at. Best works when no financing left or outstanding shares all converted to float.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.